Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Granisetron 1mg/1ml solution for injection ampoules
0406000M0AAAFAF
|
Granisetron hydrochloride | Granisetron hydrochloride | Central Nervous System | No data available |
|
Granisetron 200micrograms/ml oral solution sugar free
0406000M0AAAEAE
|
Granisetron hydrochloride | Granisetron hydrochloride | Central Nervous System | No data available |
|
Granny Ann High Fibre biscuits
090900000BBKLA0
|
Proprietary compound preparation BNF 0909000 | Other food preparations | Nutrition and Blood | No data available |
|
Granocyte 13million unit inj vials
0901060K0BBADAB
|
Granocyte | Lenograstim | Nutrition and Blood | No data available |
|
Granocyte 34million unit inj pre-filled syringes
0901060K0BBAFAD
|
Granocyte | Lenograstim | Nutrition and Blood | No data available |
|
Granocyte 34million unit inj vials
0901060K0BBACAA
|
Granocyte | Lenograstim | Nutrition and Blood | No data available |
|
Granpidam 20mg tablets
0205010Y0BCAAAA
|
Granpidam | Sildenafil(Vasodilator Antihypertensive) | Cardiovascular System | No data available |
|
Granudacyn Wound Gel dressing
20033000062
|
Granudacyn Wound Gel dressing | Wound Management & Other Dressings | Dressings | No data available |
|
Great Ormond Street Minicare urostomy bag clear
23965859600
|
Great Ormond Street Minicare urostomy bag clear | Urostomy Bags | Stoma Appliances | No data available |
|
Great Ormond Street Minicare urostomy bag opaque
23965859601
|
Great Ormond Street Minicare urostomy bag opaque | Urostomy Bags | Stoma Appliances | No data available |
|
Greek Sage herb tincture
190606000BCTBA0
|
Proprietary compound preparation BNF 1906060 | Other tincture preparations | Other Drugs and Preparations | No data available |
|
GreenFine lancets 0.36mm/28gauge
21012600244
|
GreenFine lancets 0.36mm/28gauge | Other Appliances | Appliances | No data available |
|
Gregoderm ointment
1304000V0CLABCR
|
Gregoderm | Hydrocortisone | Skin | No data available |
|
Grip-Lok Foley catheter securement device (2800FCS)
21012200124
|
Grip-Lok Foley catheter securement device (2800FCS) | Other Appliances | Appliances | No data available |
|
Griseofulvin 1.25g/5ml oral suspension
0502050B0AACDCD
|
Griseofulvin (Systemic) | Griseofulvin | Infections | No data available |
|
Griseofulvin 100mg/5ml oral suspension
0502050B0AAALAL
|
Griseofulvin (Systemic) | Griseofulvin | Infections | No data available |
|
Griseofulvin 105mg/5ml oral suspension
0502050B0AABWBW
|
Griseofulvin (Systemic) | Griseofulvin | Infections | No data available |
|
Griseofulvin 10mg/5ml oral suspension
0502050B0AACBCB
|
Griseofulvin (Systemic) | Griseofulvin | Infections | No data available |
|
Griseofulvin 110mg/5ml oral suspension
0502050B0AACFCF
|
Griseofulvin (Systemic) | Griseofulvin | Infections | No data available |
|
Griseofulvin 112.5mg/5ml oral suspension
0502050B0AAANAN
|
Griseofulvin (Systemic) | Griseofulvin | Infections | No data available |
|
Griseofulvin 12.5mg/5ml oral suspension
0502050B0AABGBG
|
Griseofulvin (Systemic) | Griseofulvin | Infections | No data available |
|
Griseofulvin 120mg/5ml oral suspension
0502050B0AABJBJ
|
Griseofulvin (Systemic) | Griseofulvin | Infections | No data available |
|
Griseofulvin 130mg/5ml oral suspension
0502050B0AACLCL
|
Griseofulvin (Systemic) | Griseofulvin | Infections | No data available |
|
Griseofulvin 135mg/5ml oral suspension
0502050B0AACJCJ
|
Griseofulvin (Systemic) | Griseofulvin | Infections | No data available |
|
Griseofulvin 140mg/5ml oral suspension
0502050B0AAASAS
|
Griseofulvin (Systemic) | Griseofulvin | Infections | No data available |
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.